Adiposity, fractional exhaled nitric oxide, and asthma in U.S. children

Yueh-Ying Han1, Erick Forno, Juan C Celedón

  • 1Division of Pediatric Pulmonary Medicine, Allergy, and Immunology, Children's Hospital of Pittsburgh of UPMC, University of Pittsburgh, Pittsburgh, Pennsylvania.

Insights

Childhood obesity is linked to asthma, but allergic airway inflammation plays a key role. Higher body fat is associated with asthma in children with low fractional exhaled nitric oxide (FeNO) and worse asthma control in those with high FeNO.

Area of Science:

  • Pediatric Allergy and Immunology
  • Respiratory Medicine
  • Obesity Research

Background:

  • The relationship between childhood overweight/obesity and asthma is complex and not fully understood.
  • The role of allergic airway inflammation, specifically eosinophilic inflammation, as a mediator is unclear.

Purpose of the Study:

  • To investigate the associations between adiposity, asthma, and fractional exhaled nitric oxide (FeNO) in a U.S. pediatric population.
  • To determine if FeNO modifies the relationship between obesity and asthma outcomes.

Main Methods:

  • Cross-sectional analysis of 2,681 children aged 6-17 years from the National Health and Nutrition Examination Survey (2007-2010).
  • Adiposity assessed using body mass index (BMI), percent body fat (PBF), and waist circumference (WC).
  • Fractional exhaled nitric oxide (FeNO) measured as a biomarker of eosinophilic airway inflammation.

Main Results:

  • Adiposity indicators (BMI, PBF, WC) were associated with asthma in children with low FeNO.
  • Among children with asthma, adiposity was linked to worse asthma severity or control in those with high FeNO.
  • In children without asthma, adiposity was associated with altered lung function (FEV1, FVC, FEV1/FVC).

Conclusions:

  • Adiposity is associated with asthma in children with low fractional exhaled nitric oxide (FeNO).
  • In children with asthma, adiposity indicators correlate with poorer asthma control and severity, particularly in those with elevated FeNO levels.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
32
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
88
Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
38
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.6K
Breathing01:05

Breathing

The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
50.3K